The 2025 study found that seasonal non-mRNA vaccines for influenza and pneumonia did not show the same tumor responsiveness or survival-associated effects as the mRNA COVID-19 vaccine when administered near the start of immune checkpoint inhibitor therapy.
October 19, 2025
high
temporal
Comparative observation within the clinical dataset contrasting mRNA COVID-19 vaccine effects with non-mRNA influenza and pneumococcal vaccines.